Lilly
Menu closed
Lilly
  • House Immunology Portal
      • Dermatology
      • Taltz® (ixekizumab) in PsO
      • Olumiant® (baricitinib) in AD
      • Rheumatology
      • Taltz® (ixekizumab) in PsA
      • Taltz® (ixekizumab) in AS
      • Olumiant® (baricitinib) in RA
      • Emgality
Ask Lilly

We're here to help.

Phone Call:
1800 454 559
Expand contact lilly

Sitemap

  • Immunology Portal
    • Dermatology
      • Taltz® (ixekizumab) in PsO
      • Olumiant® (baricitinib) in AD
    • Rheumatology
      • Taltz® (ixekizumab) in PsA
      • Taltz® (ixekizumab) in AS
      • Olumiant® (baricitinib) in RA
  • Contact Us
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap
 For Medical Information:
Call 1800 4 LILLY 1800 454 559

©2024 Copyright Eli Lilly and Company. Eli Lilly Australia Pty Limited. Level 9, 60 Margaret Street, Sydney, NSW 2000 Australia.

This website is intended for Australian Healthcare Professionals only.

TALTZ®, OLUMIANT® & EMGALITY® are registered trademarks of Eli Lilly and Company.

Date of Preparation: March 2024 PP-BA-AU-0881

Contact Us Terms of Use Privacy Statement Accessibility Statement Sitemap
Lilly